Bharti airtel sheds 6 pc on TRAI recommendations

TRAI has recommended six fold hike in start-up 2G spectrum

PTI | February 10, 2011



Shares of telecom giant Bharti airtel fell by nearly 6 per cent in early trade on the BSE today, following a heavy sell-off by investors amid confusion over telecom regulator TRAI's new recommendations on 2G spectrum pricing.

The Telecom Regulatory Authority of India (TRAI) has recommended a six-fold hike in the price of start-up 2G spectrum and has said that every Mhz of additional spectrum (on an all-India basis) beyond the contracted limit of 6.2 Mhz will cost a massive Rs 4,571.87 crore.

Bharti airtel holds extra spectrum beyond 6.2 Mhz and the new norms would impose a huge financial burden on the company.

Furthermore, the company will have to pay a hefty amount to renew its licence as per the new norms recommended by TRAI.

Reacting sharply to the development, shares of Bharti airtel slipped by 5.82 per cent to an intra-day low of Rs 313 on the Bombay Stock Exchange.

In a similar fashion, the scrip declined by 5.7 per cent to Rs 313.20 in early trade on the National Stock Exchange.

"The impact of spectrum pricing on cash flows could be severe if the recommendations are accepted, adding to operators' woes due to MNP and 3G-related pressure on business," Edelweiss Research said in a note.

Meanwhile, shares of state-run telecom firm MTNL, which also holds extra spectrum, plummeted by 4.75 per cent to hit a life-time low of Rs 39.05 apiece on the BSE.

However, another private telecom firm, Anil Ambani-led Reliance Communications, staged a smart recovery with a gain of 7.22 per cent, after plunging by nearly 18 per cent yesterday.

Meanwhile, the 30-share benchmark Sensex was down 150.69 points from its previous close at 1049 hours, at 17,442.08.

 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter